Welcome to our dedicated page for Atlanta Braves Holdings SEC filings (Ticker: BATRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Atlanta Braves Holdings, Inc. filings document formal disclosures for a public holding company whose operating assets include the Atlanta Braves Major League Baseball Club, Truist Park and The Battery Atlanta. Form 8-K reports furnish quarterly and annual operating results by Baseball and Mixed-Use Development, with discussion of revenue sources, operating costs, Adjusted OIBDA and Regulation FD announcements such as BravesVision.
Proxy materials disclose annual meeting matters, stockholder voting procedures and governance proposals. The filings also identify the company's common stock classes, Nasdaq listing information and incorporation jurisdiction for a business combining professional sports operations, stadium activities and mixed-use real estate.
Atlanta Braves Holdings investor John C. Malone filed an amended Schedule 13D showing he now beneficially holds a majority of the company’s voting power. He owns 557,039 shares of Series A common stock (about 5.4% of that class) and 949,201 shares of Series B common stock (about 97.1% of that class), giving him approximately 50.01% of the voting power in director elections.
Recent purchases include 4,631 and 2,259 Series A shares in November 2025 at prices around $42, 3,669 Series B shares on February 4, 2026 at $48.17, and 35,000 Series A shares on February 5, 2026 at a volume-weighted average price of $44.23. Because he now holds a voting majority, the company will be deemed a “Controlled Company” under Nasdaq rules, and Malone can exert significant influence over the board, major transactions, and other matters requiring shareholder approval.
Atlanta Braves Holdings, Inc. investor John C. Malone has updated his ownership, reporting beneficial control of about 50.01% of the company’s voting power in director elections through Series A and high‑vote Series B common stock.
He directly and indirectly holds 557,039 shares of Series A Common Stock, or about 5.4% of that class, and 949,201 shares of Series B Common Stock, or about 97.1% of that class, based on the share counts outstanding as of October 31, 2025. Recent purchases include multiple open‑market buys of Series A between $41.96 and $44.74 per share and a privately negotiated Series B purchase at $48.17 per share.
Because Malone now beneficially holds more than a majority of the outstanding voting securities, Atlanta Braves Holdings will be deemed a “Controlled Company” under Nasdaq rules, giving him significant influence over the board, major transactions and other matters requiring shareholder approval, subject to Major League Baseball rules and existing voting agreements.
John C. Malone, a 10% owner of Atlanta Braves Holdings, Inc., reported open-market-like purchases of the company’s common stock. On February 5, 2026, he acquired 35,000 shares of Series A Common Stock at a weighted average price of $44.23, bringing his direct Series A holdings to 521,862 shares. On February 4, 2026, he purchased 3,669 shares of Series B Common Stock in a private transaction at $48.17, and now directly holds 3,669 Series B shares. He also has indirect exposure through entities: 887,079 Series B shares are held by JCM AB LLC, and 10,177 Series A and 47,585 Series B shares are held by the Leslie A. Malone 1995 Revocable Trust, for which he disclaims beneficial ownership.
Atlanta Braves Holdings executive Jill L. Robinson exercised stock options and sold shares of Series C Common Stock. On 02/02/2026, she exercised options for 20,000 BATRK shares at an exercise price of $27.18 per share and received 20,000 shares.
That same day, she sold 20,000 Series C Common shares at a weighted average price of $40.00 per share, within a range of $39.71 to $40.22, under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025. After these transactions, she directly owned 79,460 Series C Common shares and held 90,263 stock options.
A shareholder of BATRA, identified as Jill Robinson, has filed a Form 144 indicating an intention to sell 20,000 shares of Series C Common Stock through UBS Financial Services on NASDAQ at an aggregate market value of $800,028.
The shares are scheduled for approximate sale on February 2, 2026 and were acquired the same day via a cash exercise of stock options for 20,000 shares. The issuer had 51,627,382 shares outstanding of the same class at the time referenced. Robinson also sold Series C Common shares in three prior transactions over the past three months, with individual sales of 20,000, 6,875 and 3,830 shares.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 733,932 shares of Atlanta Braves Holdings Inc common stock, representing 7.11% of the class as of the event date of 12/31/2025.
Vanguard reports shared voting power over 144,675 shares and shared dispositive power over all 733,932 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The filing also notes that on 01/12/2026 Vanguard underwent an internal realignment, after which certain subsidiaries or business divisions with beneficial ownership will report on a disaggregated basis. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends or sale proceeds, but no single other person has more than a 5% interest in these securities.
The Vanguard Group reported beneficial ownership of 2,789,081 shares of Atlanta Braves Holdings Inc. common stock, representing 5.4% of the class as of the event date 12/31/2025.
Vanguard reports shared voting power over 326,604 shares and shared dispositive power over all 2,789,081 shares, with no sole voting or dispositive power. The shares are held on behalf of Vanguard’s clients, none of whom individually owns more than 5% of the class. Vanguard notes an internal realignment effective 01/12/2026, after which certain subsidiaries are expected to report beneficial ownership separately.
Atlanta Braves Holdings, Inc.'s EVP, CLO & Secretary reported vesting of restricted stock units and a related share sale in Series C common stock.
On December 11, 2025, 7,660 restricted stock units converted into 7,660 shares of Series C common stock at $0, resulting in 30,164 shares directly owned. On December 12, 2025, the officer sold 7,423 shares at a weighted average price of $39.71, in part to cover tax withholding obligations, and afterward held 22,741 Series C shares and 7,661 restricted stock units.
Atlanta Braves Holdings, Inc. executive vice president of development reported equity award activity involving Series C Common Stock (BATRK). On December 11, 2025, 11,142 restricted stock units converted into an equal number of shares at $0, bringing direct holdings to 250,467 shares. On December 12, 2025, 4,874 shares were sold at a weighted average price of $39.74 to cover tax withholding tied to the vesting, leaving 245,593 shares held directly. The report also notes 55,503 shares held indirectly through a grantor retained annuity trust and 11,142 restricted stock units outstanding, with the remaining units scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. reported that its EVP, CFO & Treasurer converted 7,660 restricted stock units into Series C Common Stock on December 11, 2025, at an exercise price of $0 per share. On December 12, 2025, the executive sold 3,830 Series C shares in an open-market transaction coded as a sale, at a weighted average price of $39.70.
The sale was carried out under a Rule 10b5-1 sales plan adopted on May 15, 2025 and was intended to cover tax withholding obligations tied to the RSU vesting. The price range for the sale was from $39.37 to $40.12. After these transactions, the executive directly held 79,460 Series C shares, and the remaining restricted stock units continue vesting in tranches, with the final portion scheduled to vest on December 11, 2026.